Yasser Mahfooth Tabana

Dr. Yasser Mahfooth Tabana


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SDSaad Dahham
Saad Dahham
YTYasser Mahfooth Tabana
Yasser Mahfooth Tabana
MAMuhammmad Asif
Muhammmad Asif
MAMarawan Ahmed
Marawan Ahmed
DBDinesh Babu
Dinesh Babu
AMAmin M. S. A. Majid
Amin M. S. A. Majid
Beta-Caryophyllene (BCP), a naturally occurring sesquiterpene abundantly found in cloves, hops, and cannabis, is the active candidate of a relatively new group of vascular-inhibiting compounds that aim to block existing tumor blood vessels. Previously, we have reported the anti-cancer properties of BCP by utilizing a series of in-vitro anti-tumor-related assays using human colorectal carcinoma cells. The present study aimed to investigate the effects of BCP on in-vitro, ex-vivo, and in-vivo models of anti-angiogenic assays and evaluate its anti-cancer activity in xenograft tumor (both ectopic and orthotopic) mice models of human colorectal cancer. Computational structural analysis and an apoptosis antibody array were also performed to understand the molecular players underlying this effect. BCP exhibited strong anti-angiogenic activity by blocking the migration of endothelial cells, tube-like network formation, suppression of vascular endothelial growth factor (VEGF) secretion from human umbilical vein endothelial cells and sprouting of rat aorta microvessels. BCP has a probable binding at Site#0 on the surface of VEGFR2. Moreover, BCP significantly deformed the vascularization architecture compared to the negative control in a chick embryo chorioallantoic membrane assay. BCP showed a remarkable reduction in tumor size and fluorescence molecular tomography signal intensity in all the mice treated with BCP, in a dose-dependent relationship, in ectopic and orthotopic tumor xenograft models, respectively. The histological analysis of the tumor from BCP-treated mice revealed a clear reduction of the density of vascularization. In addition, BCP induced apoptosis through downregulation of HSP60, HTRA, survivin, and XIAP, along with the upregulation of p21 expressions. These results suggest that BCP acts at multiple stages of angiogenesis and could be used as a promising therapeutic candidate to halt the growth of colorectal tumor cells.

28 January 2023 in Life
Verified
Journal Article
Open access
PDF file
BLBronwyn Lok
Bronwyn Lok
DBDinesh Babu
Dinesh Babu
YTYasser Mahfooth Tabana
Yasser Mahfooth Tabana
SDSaad Dahham
Saad Dahham
MAMowaffaq Adam Ahmed Adam
Mowaffaq Adam Ahmed Adam
DSDoblin Sandai
Doblin Sandai
The fruits, leaves, and bark of the guava (Psidium guajava) tree have traditionally been used to treat a myriad of ailments, especially in the tropical and subtropical regions. The various parts of the plant have been shown to exhibit medicinal properties, such as antimicrobial, antioxidant, anti-inflammatory, and antidiabetic activities. Recent studies have shown that the bioactive phytochemicals of several parts of the P. guajava plant exhibit anticancer activity. This review aims to present a concise summary of the in vitro and in vivo studies investigating the anticancer activity of the plant against various human cancer cell lines and animal models, including the identified phytochemicals that contributes to their activity via the different mechanisms. In vitro growth and cell viability studies, such as the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, the sulforhodamine B (SRB) assay, and the trypan blue exclusion test, were conducted using P. guajava extracts and their biomolecules to assess their effects on human cancer cell lines. Numerous studies have showcased that the P. guajava plant and its bioactive molecules, especially those extracted from its leaves, selectively suppress the growth of human cancer cells without cytotoxicity against the normal cells. This review presents the potential of the extracts of P. guajava and the bioactive molecules derived from it, to be utilized as a feasible alternative or adjuvant treatment for human cancers. The availability of the plant also contributes towards its viability as a cancer treatment in developing countries.

23 April 2018 in Biomedicines
Verified
Journal Article
Open access
PDF file
SKSaba Khalilpour
Saba Khalilpour
GBGhazaleh Behnammanesh
Ghazaleh Behnammanesh
FAFsr Al-Suede
Fsr Al-Suede
MEMohammed Ezzat
Mohammed Ezzat
JMJayadhisan Muniandy
Jayadhisan Muniandy
AMAman Shah Majid
Aman Shah Majid
Modulating oxidative stresses and inflammation can potentially prevent or alleviate the pathological conditions of diseases associated with the nervous system, including ischemic optic neuropathy. In this study we evaluated the anti-neuroinflammatory and neuroprotective activities of Rhus coriaria (R. coriaria) extract in vivo. The half maximal inhibitory concentration (IC50) for DPPH, ABTS and β–carotene were 6.79 ± 0.009 µg/mL, 10.94 ± 0.09 µg/mL, and 6.25 ± 0.06 µg/mL, respectively. Retinal ischemia was induced by optic nerve crush injury in albino Balb/c mice. The anti-inflammatory activity of ethanolic extract of R. coriaria (ERC) and linoleic acid (LA) on ocular ischemia was monitored using Fluorescence Molecular Tomography (FMT). Following optic nerve crush injury, the mice treated with 400 mg/kg of ERC and LA exhibited an 84.87% and 86.71% reduction of fluorescent signal (cathepsin activity) respectively. The results of this study provide strong scientific evidence for the neuroprotective activity of the ERC, identifying LA as one of the main components responsible for the effect. ERC may be useful and worthy of further development for its adjunctive utilization in the treatment of optic neuropathy.
1

18 March 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
HQHaitham Qaralleh
Haitham Qaralleh
SSSultan Ayesh Mohammed Saghir
Sultan Ayesh Mohammed Saghir
MAMuhamad O. Al-Limoun
Muhamad O. Al-Limoun
SDsaif Mamdouh dmour
saif Mamdouh dmour
KKKhaled M. Khleifat
Khaled M. Khleifat
AAAbdulaziz M. Alqahtani
Abdulaziz M. Alqahtani
The emergence of drug-resistant microorganisms presents a substantial global public health threat. The increase in pathogens resistant to commonly prescribed antibiotics underscores the urgent requirement to explore alternative treatment strategies. This study adopts a novel approach by harnessing natural resources, specifically essential oils (EO), to combat bacterial pathogenicity. The primary aim of this research was to analyze the chemical composition of the aerial part of the Matricaria aurea (M. aureas) EO and evaluate its potential for inhibiting quorum sensing (QS) and disrupting biofilm formation in Pseudomonas aeruginosa (P. aeruginosa). The gas chromatography-mass spectrometry (GCMS) analysis unveiled that α-bisabolol oxide A constituted the predominant portion, comprising 64.8% of the total, with β-bisabolene at 6.3% and α-farnesene at 4.8% following closely behind. The antibiofilm efficacy was observed at concentrations of 0.3, 0.15, and 0.08 mg/mL, demonstrating negligible effects on cell viability. Furthermore, the EO from M. aurea effectively inhibited the formation of P. aeruginosa biofilms by diminishing aggregation, hydrophobicity, and swarming motility. Significantly, the EO treatment resulted in a conspicuous decrease in the production of pyocyanin, rhamnolipid, and extracellular polymeric substances (EPS), along with a reduction in the enzymatic activity of protease and chitinase. The EO effectively hindered QS by disrupting QS mechanisms, resulting in a marked decline in the secretion of N-Acyl homoserine lactone (AHL) molecules and the expression of phazA1 and aprA genes. This investigation offers compelling evidence supporting the potential of M. aurea EO as a promising therapeutic candidate for addressing infectious diseases induced by biofilm formation.

Verified
Journal Article
Open access
PDF file
MAMowaffaq Adam Ahmed Adam
Mowaffaq Adam Ahmed Adam
LKLaina Zarisa Muhd Kamal
Laina Zarisa Muhd Kamal
MKMahibub Muhamadsa Muhamadsa Kanakal
Mahibub Muhamadsa Muhamadsa Kanakal
DBDinesh Babu
Dinesh Babu
SDSaad Dahham
Saad Dahham
DSDoblin Sandai
Doblin Sandai
The fungal toxin aflatoxin B1 (AB1) and its reactive intermediate, aflatoxin B1-8, 9 epoxide, could cause liver cancer by inducing DNA adducts. AB1 exposure can induce changes in the expression of several cancer-related genes. In this study, the effect of AB1 exposure on breast cancer MCF7 and normal breast MCF10A cell lines at the phenotypic and epigenetic levels was investigated to evaluate its potential in increasing the risk of breast cancer development. We hypothesized that, even at low concentrations, AB1 can cause changes in the expression of important genes involved in four pathways, i.e., p53, cancer, cell cycle, and apoptosis. The transcriptomic levels of BRCA1, BRCA2, p53, HER1, HER2, cMyc, BCL2, MCL1, CCND1, WNT3A, MAPK1, MAPK3, DAPK1, Casp8, and Casp9 were determined in MCF7 and MCF10A cells. Our results illustrate that treating both cells with AB1 induced cytotoxicity and apoptosis with reduction in cell viability in a concentration-dependent manner. Additionally, AB1 reduced reactive oxygen species levels. Phenotypically, AB1 caused cell-cycle arrest at G1, hypertrophy, and increased cell migration rates. There were changes in the expression levels of several tumor-related genes, which are known to contribute to activating cancer pathways. The effects of AB1 on the phenotype and epigenetics of both MCF7 and MCF10A cells associated with cancer development observed in this study suggest that AB1 is a potential risk factor for developing breast cancer.

24 April 2019
Verified
Book Chapter
Open access
PDF file
DSDoblin Sandai
Doblin Sandai
YTYasser Mahfooth Tabana
Yasser Mahfooth Tabana
RSRosline Sandai
Rosline Sandai
This topic was to examine the impact of galactose or fructose upon the assimilation of secondary carbon sources by Candida albicans. C. albicans ICL1 gene is repressed upon addition of 2% galactose or fructose to lactate- and oleic acid-grown cells. Further studies on CaFOX2, CaFBP1 and CaMLS1 transcripts in response to galactose or fructose on assimilation of lactate and oleic acid resulted in repression of these genes. The CaICL1 gene, which encode the glyoxylate cycles enzymes isocitrate lyase are required for growth on non-fermentable carbon sources. However, the enzyme CaIcl1 was not destabilized by galactose, but was degraded in response to fructose. In contrast, S. cerevisiae Icl1 has retained the molecular apparatus of protein degradation in response to either galactose or fructose. Screening of ubiquitination site by http://www.ubpred.org/ showed that C. albicans lacks ubiquitination site in gluconeogenic and glyoxylate cycles enzymes as compare to S. cerevisiae. Addition of a putative S. cerevisiae ubiquitination site carboxy terminus of CaIcl1 led to galactose- accelerated degradation of this protein in C. albicans cell via a ubiquitin-dependent process. In the other hand, CaIcl prior to addition of ubiquitination site was degraded upon exposure to fructose; addition of S. cerevisiae ubiquitination site to CaIcl1 further increased the speed of protein degradation.